Millions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty
GLP-1 agonists have rewritten the rules of weight management almost overnight—and in the process created one of the biggest nutrition challenges (and opportunities) formulators have seen in decades.
For brands paying
GLP-1 drugs like Ozempic and Wegovy are reshaping weight management. The results are undeniable—but the side effects are too. That’s why companion solutions aren’t optional anymore. They’re essential.
Why Gut Health